Abstract
Psoriasis is a common skin disorder characterized by hyper proliferation of keratinocytes. Although the exact pathophysiology of psoriasis is not entirely understood, immune system and its interaction with nervous system have been postulated and investigated as the underlying mechanism. The interaction between these two systems through cholinergic anti-inflammatory pathway and also endocannabinoid system, may suggest cannabinoids as potential addition to antipsoriatic armamentarium.
Keywords: Psoriasis, immunomodulation, cannabidiol, endocannabinoids, vagal nerve stimulation.
Current Clinical Pharmacology
Title:Cannabis for Refractory Psoriasis—High Hopes for a Novel Treatment and a Literature Review
Volume: 11 Issue: 2
Author(s): Nima Derakhshan and Mahboubeh Kazemi
Affiliation:
Keywords: Psoriasis, immunomodulation, cannabidiol, endocannabinoids, vagal nerve stimulation.
Abstract: Psoriasis is a common skin disorder characterized by hyper proliferation of keratinocytes. Although the exact pathophysiology of psoriasis is not entirely understood, immune system and its interaction with nervous system have been postulated and investigated as the underlying mechanism. The interaction between these two systems through cholinergic anti-inflammatory pathway and also endocannabinoid system, may suggest cannabinoids as potential addition to antipsoriatic armamentarium.
Export Options
About this article
Cite this article as:
Derakhshan Nima and Kazemi Mahboubeh, Cannabis for Refractory Psoriasis—High Hopes for a Novel Treatment and a Literature Review, Current Clinical Pharmacology 2016; 11 (2) . https://dx.doi.org/10.2174/1574884711666160511150126
DOI https://dx.doi.org/10.2174/1574884711666160511150126 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Ultrasound-Directed Drug Delivery
Current Pharmaceutical Biotechnology Viral Infection - A Cure for Type 1 Diabetes?
Current Medicinal Chemistry Innovative Erythrocyte-based Carriers for Gene Delivery in Porcine Vascular Smooth Muscle Cells: Basis for Local Therapy to Prevent Restenosis
Cardiovascular & Hematological Disorders-Drug Targets Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
Current Pharmaceutical Design Probiotics as an Adjuvant for Management of Gastrointestinal Cancers through their Anti-inflammatory Effects: A Mechanistic Review
Current Medicinal Chemistry ABC Subfamily D Proteins and Very Long Chain Fatty Acid Metabolism as Novel Targets in Adrenoleukodystrophy
Current Drug Targets Impact of Phytomolecules with Nanotechnology on the Treatment of Inflammation
Current Bioactive Compounds Anticarcinogenic Effects of Capsaicin-Loaded Nanoparticles on In vitro Hepatocellular Carcinoma
Current Chemical Biology Bone Marrow Niches for Hematopoietic Stem Cells and Immune Cells
Inflammation & Allergy - Drug Targets (Discontinued) A Closer Look at “Social” Boundary Genes Reveals Knowledge to Gene Expression Profiles
Current Protein & Peptide Science Endothelial Lessons
Current Vascular Pharmacology Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Current Cancer Therapy Reviews Effect of Variable Doses of Paederia foetida L. Combat Against Experimentally- Induced Systemic and Topical Inflammation in Wistar Rats
Current Bioactive Compounds Inflammatory Mechanisms of Adverse Reactions to BMS
Current Vascular Pharmacology The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family
Current Pharmaceutical Design Differential Expression of Genes in Obesity and Type 2 Diabetes Mellitus
Current Nutrition & Food Science Apoptotic and Anti-Angiogenic Effects of Benzimidazole Compounds: Relationship with Oxidative Stress Mediated Ischemia/Reperfusion Injury in Rat Hind Limb
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design Nanomedicines as Cancer Therapeutics: Current Status
Current Cancer Drug Targets Intravenous Immunoglobulın Therapy in Dermatology: An Update
Inflammation & Allergy - Drug Targets (Discontinued)